TrialDiabetes, obesity & metabolism2022

Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add-on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care (LIRA-PRIME).

Jeff Unger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.